Point-of-Care Lateral Flow Assays for Tuberculosis and Cryptococcal Antigenuria Predict Death in HIV Infected Adults in Uganda
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Mortality in hospitalized, febrile patients in Sub-Saharan Africa is high due to HIV-infected, severely immunosuppressed patients with opportunistic co-infection, particularly disseminated tuberculosis (TB) and cryptococcal disease. We sought to determine if a positive lateral flow assay (LFA) result for urine lipoarabinomannan (LAM) and cryptococcal antigenuria was associated with mortality. METHODS: 351 hospitalized, HIV-positive adults with symptoms consistent with TB and who were able to provide both urine and sputum specimens were prospectively enrolled at Mulago National Referral Hospital in Uganda as part of a prospective accuracy evaluation of the lateral flow Determine TB LAM test. Stored frozen urine was retrospectively tested for cryptococcal antigen (CRAG) using the LFA. We fitted a multinomial logistic regression model to analyze factors associated with death within 2 months after initial presentation. RESULTS: The median CD4 of the participants was 57 (IQR: 14-179) cells/µl and 41% (145) were microbiologically confirmed TB cases. LAM LFA was positive in 38% (134), 7% (25) were CRAG positive, and 43% (151) were positive for either test in urine. Overall, 21% (75) died within the first 2 months, and a total of 32% (114) were confirmed dead by 6 months. At 2 months, 30% of LAM or CRAG positive patients were confirmed dead compared to 15.0% of those who were negative. In an adjusted model, LAM or CRAG positive results were associated with an increased risk of death (RRR 2.29, 95% CI: 1.29, 4.05; P = 0.005). CONCLUSIONS: In hospitalized HIV-infected patients, LAM or CRAG LFA positivity was associated with subsequent death within 2 months. Further studies are warranted to examine the impact of POC diagnostic 'test and treat' approach on patient-centered outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bjerrum, S., Schiller, I., Dendukuri, N., Kohli, M., Nathavitharana, R. R., Zwerling, A. A., Denkinger, C. M., Steingart, K. R., & Shah, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011420.pub3 · Cited by 186
Self-citationThe epidemiology of febrile illness in sub-Saharan Africa: implications for diagnosis and management
Maze, M. J., Bassat, Q., Feasey, N. A., Mandomando, I., Musicha, P., & Crump, J. A. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.02.011 · Cited by 170
“Although trials are needed, there is a case for further 352 development of RDTs to diagnose disseminated tuberculosis (89), or the 353 inclusion of anti-tuberculosis therapy as empiric treatment for adults with 354 advanced HIV who present with sepsis (90).”
BackgroundFord, N., Shubber, Z., Jarvis, J. N., Chiller, T., Greene, G., Migone, C., Vitoria, M., Doherty, M., & Meintjes, G. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1143 · Cited by 113
“Thirteen studies reported the prevalence of TB disease among patients who were CrAg positive, using different TB screening approaches [9, 11, 19–22, 26, 28, 33, 41, 46, 57, 72].”
Parkes‐Ratanshi, R., Achan, B., Kwizera, R., Kambugu, A., Meya, D., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12387 · Cited by 49
Inverting the pyramid: increasing awareness of mycobacterial sepsis in sub-Saharan Africa
Cummings, M. J., & O'Donnell, M. R. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0967 · Cited by 23
Metadata
- Authors
- Manabe, Y. C., Nonyane, B. A. S., Nakiyingi, L., Mbabazi, O., Lubega, G., Shah, M., Moulton, L. H., Joloba, M., Ellner, J., & Dorman, S. E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-07-07
- Volume
- 9
- Issue
- 7
- Pages
- e101459
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2082506313
- Cited by
- 45
- References
- 0
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.